Northwest Biotherapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 22
- Market Cap
- -
- Website
- http://www.nwbio.com
Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer
- Conditions
- Brain MetastasesLung Cancer MetastaticBreast Cancer Metastatic
- Interventions
- Biological: DCVax-Direct
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2018-08-20
- Lead Sponsor
- Northwest Biotherapeutics
- Target Recruit Count
- 24
- Registration Number
- NCT03638765
- Locations
- 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
- Conditions
- GBMGlioblastoma Multiforme
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- Northwest Biotherapeutics
- Registration Number
- NCT02146066
- Locations
- 🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸Geisinger Medical Center, Danville, Pennsylvania, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
- Conditions
- Colorectal CancerPancreatic CancerLocally Advanced TumorMetastatic Solid Tissue TumorsLiver CancerMelanoma
- Interventions
- Biological: DCVax-Direct
- First Posted Date
- 2013-06-21
- Last Posted Date
- 2015-10-07
- Lead Sponsor
- Northwest Biotherapeutics
- Target Recruit Count
- 60
- Registration Number
- NCT01882946
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Orlando Health, Orlando, Florida, United States
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
- Conditions
- Grade IV AstrocytomaBrain CancerGlioblastomaGliomaBrain TumorGlioblastoma MultiformeGBM
- Interventions
- Drug: Dendritic cell immunotherapy
- First Posted Date
- 2002-09-19
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- Northwest Biotherapeutics
- Target Recruit Count
- 348
- Registration Number
- NCT00045968
- Locations
- 🇺🇸
Colorado Neurological Institute, Englewood, Colorado, United States
🇺🇸Sutter East Bay Neuroscience Institute-Eden Medical Center, Castro Valley, California, United States
🇺🇸City of Hope, Duarte, California, United States
Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.
- Conditions
- Prostate Cancer
- First Posted Date
- 2002-08-08
- Last Posted Date
- 2013-05-01
- Lead Sponsor
- Northwest Biotherapeutics
- Registration Number
- NCT00043212
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸Albany Regional Cancer Center, Albany, New York, United States
🇺🇸Cleveland Clinic Foundation, Cleveland, Ohio, United States